BLRX

Biolinerx Ltd.

An Israeli biopharmaceutical company that finds promising experimental drugs from academic labs and biotech startups and shepherds them through clinical trials. Its first FDA-approved medicine, APHEXDA, helps mobilize stem cells for transplant, and it is also developing treatments for hard-to-treat cancers. Founded in 2003 as a joint venture backed by Teva, the Hadassah Medical Center's tech-transfer arm, and the Jerusalem Development Authority, its name blends "bio," "pipeline," and "Rx" (the medical prescription symbol).

American Depositary Shares, each representing 600 ordinary shares